Replies to post #58113 on Biotech Values

[DewDiligence]

Thanks! I’ll get that in the next revision.

p.s. Did you ever get back into IDIX?

[DewDiligence]

Re: FLML

>somewhere below locteron (since we haven't seen the full VL data yet), but above "the other interferons", since there is positive top line data in a comparator clinical trial vs pegylated interferon<

In reviewing FLML’s PR from October, it seems that all we have is the company’s assurance that the top-line data were positive (#msg-24008801). Therefore, I think I’ll put IFN-alpha-XL in the same group with Albuferon and IFN-Lambda. Feel free to argue for a different placement :-)